Myo1c Binds Phosphoinositides Through a Putative Pleckstrin Homology Domain
Overview
Molecular Biology
Affiliations
Myo1c is a member of the myosin superfamily that binds phosphatidylinositol-4,5-bisphosphate (PIP(2)), links the actin cytoskeleton to cellular membranes and plays roles in mechano-signal transduction and membrane trafficking. We located and characterized two distinct membrane binding sites within the regulatory and tail domains of this myosin. By sequence, secondary structure, and ab initio computational analyses, we identified a phosphoinositide binding site in the tail to be a putative pleckstrin homology (PH) domain. Point mutations of residues known to be essential for polyphosphoinositide binding in previously characterized PH domains inhibit myo1c binding to PIP(2) in vitro, disrupt in vivo membrane binding, and disrupt cellular localization. The extended sequence of this binding site is conserved within other myosin-I isoforms, suggesting they contain this putative PH domain. We also characterized a previously identified membrane binding site within the IQ motifs in the regulatory domain. This region is not phosphoinositide specific, but it binds anionic phospholipids in a calcium-dependent manner. However, this site is not essential for in vivo membrane binding.
Chavali S, Carman P, Shuman H, Ostap E, Sindelar C Proc Natl Acad Sci U S A. 2025; 122(9):e2415457122.
PMID: 40014570 PMC: 11892617. DOI: 10.1073/pnas.2415457122.
Chavali S, Carman P, Shuman H, Ostap E, Sindelar C bioRxiv. 2025; .
PMID: 39829824 PMC: 11741418. DOI: 10.1101/2025.01.10.632429.
Myosin-I synergizes with Arp2/3 complex to enhance the pushing forces of branched actin networks.
Xu M, Rutkowski D, Rebowski G, Boczkowska M, Pollard L, Dominguez R Sci Adv. 2024; 10(37):eado5788.
PMID: 39270022 PMC: 11397503. DOI: 10.1126/sciadv.ado5788.
Myo1c drives actin-dependent VWF expulsion from EC WPBs.
Rusu L, Minshall R Blood Adv. 2024; 8(17):4711-4713.
PMID: 39254967 PMC: 11413664. DOI: 10.1182/bloodadvances.2024013476.
El-Mansi S, Mitchell T, Mobayen G, McKinnon T, Miklavc P, Frick M Blood Adv. 2024; 8(17):4714-4726.
PMID: 38669344 PMC: 11413703. DOI: 10.1182/bloodadvances.2024012590.